allogeneic mesenchymal stem cells derived from umbilical cord
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for allogeneic mesenchymal stem cells derived from umbilical cord, covering 2021-07-08 to 2021-07-08. Get the full timeline:
Most recent: Clinical Trial Update: Treatment of Refractory Systemic Lupus Erythematosus by Allogeneic Mesenchymal Stem Cells Derived From the Umbilical Cord [Phase 1, Phase 2]